Keyword: prostatecancer

Brevity: Headers | « Text »
  • Vitamin D Can Reverse Initial Stage Prostate Cancer: Study

    03/23/2015 9:37:47 PM PDT · by jonatron · 33 replies
    MicroFinance Monitor ^ | 3/23/2015 | staff
    Vitamin D can slow down or even reverse the initial prostate cancer or tumours without the requirement for surgery or radiation, says new research. While the researchers are not sure at this stage about the connection, they said vitamin D can at least slow down the multiplying nature of the tumour, which is crucial in initial stage prostate cancer. In many cases when the biopsy is taken, it requires 60 days for the inflammation from the biopsy to subside for an operation and during this supplements of vitamin D would be helpful, while under active surveillance, said researchers. “We do...
  • Iran rebukes 'Israeli driven rumors' that Supreme Leader Khamenei hospitalized in critical condition

    03/08/2015 5:49:13 AM PDT · by SeekAndFind · 8 replies
    Jerusalem Post ^ | 03/08/2015
    Amid reports that Iran' Supreme Leader Ayatollah Khamenei has been hospitalized in critical condition, Tehran has issued what it claims is evidence of his involvement in a public meeting with environmentalists to address Iran's natural resources On Tuesday, reports emerged claiming that the Islamic Republic's top cleric was taken into intense medical care, allegations which FARS news, an Iranian state news agency, dubbed as "Israeli driven rumors," even suggesting that the Jewish state has embarked on similar misinformation campaigns in the past. "In numerous occasions, they [Israel, Western Intelligence] have said he is ill and they've taken him to hospital,...
  • Antibiotics that target mitochondria effectively eradicate cancer stem cells...

    02/08/2015 4:37:54 PM PST · by 2ndDivisionVet · 25 replies
    Impact Journals ^ | January 22, 2015 | Various
    Abstract Here, we propose a new strategy for the treatment of early cancerous lesions and advanced metastatic disease, via the selective targeting of cancer stem cells (CSCs), a.k.a., tumor-initiating cells (TICs). We searched for a global phenotypic characteristic that was highly conserved among cancer stem cells, across multiple tumor types, to provide a mutation-independent approach to cancer therapy. This would allow us to target cancer stem cells, effectively treating cancer as a single disease of “stemness”, independently of the tumor tissue type. Using this approach, we identified a conserved phenotypic weak point – a strict dependence on mitochondrial biogenesis for...
  • Vasectomy can increase risk of developing lethal prostate cancer

    07/11/2014 8:12:37 AM PDT · by Olog-hai · 27 replies
    Daily Telegraph (UK) ^ | 10:00PM BST 10 Jul 2014 | Laura Donnelly and Claire Carter
    Men who have a vasectomy face an increased chance of developing prostate cancer and a higher risk of contracting the most aggressive form of the disease, a study has found. The Harvard research on 50,000 men, the largest study to examine the link between sterilization and cancer, found that those who had the procedure had a 10 percent greater chance of developing the disease. It also found a sharp increase in the risk of contracting the most aggressive form of prostate cancer, although this type of the disease is still relatively rare. The dangers appeared to be highest among men...
  • Prostate cancer ‘could be a sexually transmitted disease’, scientists say

    05/20/2014 8:13:20 PM PDT · by Olog-hai · 20 replies
    Belfast Telegraph ^ | 21 May 2014
    Prostate cancer could be a sexually transmitted disease caused by a common infection passed on during intercourse, scientists are claiming. Research by the University of California found a sex infection called trichomoniasis supported cancer growth when a team of scientists tested human prostate cells in a laboratory. Trichomoniasis is the most common non-viral sexually transmitted infection and is understood to have infected an estimated 275 million people around the world. …
  • Sources: Donald Sterling Has Cancer

    05/01/2014 10:09:34 PM PDT · by nickcarraway · 45 replies
    ABC News ^ | 4/2/2014
    los Angeles Clippers owner Donald Sterling is battling cancer, sources have confirmed to The news was first reported by the New York Post. The Post, citing sources, reported that the 80-year-old Sterling has been battling prostate cancer for an extended period of time. Sterling was banned for life from the NBA and fined $2.5 million by commissioner Adam Silver earlier in the week after racist remarks he made were published by TMZ. Silver has urged the league's owners to force a sale of the Clippers, which they can do with approval from three-fourths of the league's 30 owners.
  • Coburn's Principles

    01/21/2014 9:05:44 AM PST · by afraidfortherepublic · 6 replies
    Wall Street Journal ^ | 1-20-14 | Editorial Board
    Congress is more unpopular than ever, but some Members are better than its reputation. One of them is Tom Coburn, the Oklahoma Republican who announced on Friday that he'll leave the Senate at the end of this year. Mr. Coburn's second term doesn't officially end until 2016, but he is battling a recurrence of prostate cancer and said he felt he could "best serve my own children and grandchildren by shifting my focus elsewhere" than Congress. Mr. Coburn's tenure on Capitol Hill has been notable for his convictions on behalf of limited government combined with a determination to do more...
  • Okla. Sen. Coburn to retire after current session

    01/16/2014 8:09:12 PM PST · by Olog-hai · 64 replies
    Associated Press ^ | Jan 16, 2014 11:02 PM EST | Sean Murphy
    U.S. Sen. Tom Coburn will finish out the current congressional session and then resign from his seat nearly two years before his term is scheduled to end, he said in a statement released late Thursday. […] Coburn, a physician from Muskogee, recently was diagnosed with a recurrence of prostate cancer, but said his decision was not about his health. …
  • Sen. Tom Coburn diagnosed with prostate cancer

    11/05/2013 11:18:02 AM PST · by rightwingintelligentsia · 38 replies
    FoxNews ^ | November 5, 2013
    WASHINGTON – Oklahoma Republican Sen. Tom Coburn has been diagnosed with a recurrence of prostate cancer and is seeking treatment. A spokesman says Coburn, a survivor of a 2011 bout with the disease, is "undergoing further evaluation and treatment." Coburn has battled colon cancer and melanoma in the past.
  • N.Y. tax checkoff funds for cancer research sit idle

    10/13/2013 8:14:09 AM PDT · by KeyLargo · 8 replies ^ | Oct 13, 2013
    N.Y. tax checkoff funds for cancer research sit idle Since 2005, New York taxpayers have donated $1.8 million through their income tax returns to aid the fight against prostate cancer, but researchers have yet to see a dime.
  • Biomarker May Predict Prostate Cancers Requiring Treatment

    09/12/2013 7:22:42 PM PDT · by neverdem · 7 replies
    CancerNetwork ^ | September 11, 2013 | Anna Azvolinsky, PhD
    Not all early-stage prostate cancer diagnoses are alike. While some patients have aggressive tumors, others have slow-growing, low Gleason score tumors that may not require treatment, but instead can be monitored with regular clinical evaluations. But distinguishing between prostate cancers that require treatment and those that do not is still a major challenge.Researchers at Columbia University in New York City have now identified a 3-gene signature that could indicate whether a particular early-stage prostate cancer is indolent. The test relies on a tissue sample, and along with a prostate-specific antigen (PSA) test and a histology assessment, could help clinicians make...
  • Thalidomide teams-up with turmeric to kill myeloma cells

    07/02/2013 8:00:41 PM PDT · by neverdem · 53 replies
    Chemistry World ^ | 2 July 2013 | Sonja Hampel
    One of the curcumin–thalidomide hybridsCancer researchers in the US and China have combined the turmeric spice pigment curcumin and the drug thalidomide to create hybrid compounds that can kill multiple myeloma cells.Multiple myeloma is the second most common type of blood cancer, killing 20% of affected patients each year. The drug thalidomide, banned after causing birth defects when given during pregnancy in the 1950s, was recently rediscovered and approved for the treatment of multiple myeloma. Thalidomide works by disturbing the microenvironment of tumour cells in bone marrow. However, it disintegrates in the body. Curcumin, a yellow pigment from the common...
  • Best-selling author Vince Flynn dies at age 47.

    06/19/2013 9:46:50 AM PDT · by GSP.FAN · 18 replies
    Fox news ^ | June 19, 2013 | Fox news
    Flynn self-published his first book, "Term Limits," in 1997 before landing a publishing deal. "Term Limits" became a New York Times bestseller. Most of his books centered on the character Mitch Rapp, a counterterrorism operative. He averaged a book a year.
  • Gene test may help guide prostate cancer treatment

    05/07/2013 11:16:02 PM PDT · by neverdem · 5 replies
    Associated Press ^ | May 8, 2013 | MARILYNN MARCHIONE
    A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. The new test, which goes on sale Wednesday, joins another one that recently came on the market. Both analyze multiple genes in a biopsy sample and give a score for aggressiveness, similar to tests used now for certain breast and colon cancers. Doctors say tests like these have the potential to curb a major problem in cancer care — overtreatment. Prostate tumors usually grow so...
  • Damon Harris, Who Sang With the Temptations, Dies at 62

    03/16/2013 10:26:31 PM PDT · by nickcarraway · 10 replies
    New York Times ^ | February 26, 2013
    Damon Harris, who sang with the Temptations on many of their hits of the 1970s, died here on Feb. 18. He was 62. The cause was prostate cancer, said Chuck Woodson, his cousin and a family spokesman. Mr. Harris was a decade younger than anyone else in the Temptations when he joined in 1971, replacing Eddie Kendricks. He was the lead singer on “Papa Was a Rollin’ Stone,” the group’s last No. 1 single, and was also heard on “Superstar (Remember How You Got Where You Are),” “Masterpiece” and other hits. He left in 1975.
  • Author Joe McGinniss Reveals Prostate Cancer Diagnosis (Gov. Palin's creepy author next door)

    01/24/2013 2:24:48 PM PST · by 2ndDivisionVet · 31 replies
    The Wrap's Media Alley ^ | January 24, 2013 | Greg Gilman
    Joe McGinniss, the author of "Fatal Vision," "Final Vision" and a 2011 Sarah Palin biography, announced that he was diagnosed with terminal prostate cancer last May. "I was diagnosed in May with advanced, metastatic prostate cancer," he wrote Wednesday on his Facebook page. "There is no cure, so sooner or later it's terminal." --snip-- Most recently, McGinniss profiled Sarah Palin in "The Rogue: Searching for the Real Sarah Palin," which portrayed the former GOP vice presidential candidate in a less than positive manner. After renting a house neighboring Palin's Alaskan home to carry out his research, he emerged with claims...
  • New treatment for prostate cancer gives 'perfect results' for nine in ten men: research

    04/16/2012 4:49:05 PM PDT · by Free ThinkerNY · 23 replies
    The Telegraph ^ | April 16, 2012 | Rebecca Smith
    A new treatment for prostate cancer can rid the disease from nine in ten men without debilitating side effects, a study has found, leading to new hope for tens of thousands of men. It is hoped the new treatment, which involves heating only the tumours with a highly focused ultrasound, will mean men can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies. A study has found that focal HIFU, high-intensity focused ultrasound, provides the 'perfect' outcome of no major side effects and free of cancer 12 months after treatment, in...
  • Zimbabwe's Mugabe "well, on holiday": officials

    04/10/2012 4:07:30 AM PDT · by Olog-hai
    Reuters ^ | Tue Apr 10, 2012 6:37am EDT | (Reporting by Cris Chinaka; editing by Ed Stoddard and Pascal Fletcher)
    Zimbabwean officials on Tuesday dismissed reports that President Robert Mugabe was seriously ill in Singapore, saying he was well and on holiday there with his family, and was expected to return home this week. Two senior officials from Mugabe's ZANU-PF party, who declined to be named, said a website report about the 88-year-old leader battling for his life in a Singapore hospital, which was widely repeated by some international media, was not true. "The president is well and away on a private holiday to help his daughter prepare for post-graduate studies, but we are expecting him home this week," said...
  • Doctors call for end to five cancer tests, treatments

    04/04/2012 8:32:34 AM PDT · by jakerobins · 19 replies
    NEW YORK (Reuters) - In a move that threatens to further inflame concerns about the rationing of medical care, the nation's leading association of cancer physicians issued a list on Wednesday of five common tests and treatments that doctors should stop offering to cancer patients. The list emerged from a two-year effort, similar to a project other medical specialties are undertaking, to identify procedures that do not help patients live longer or better or that may even be harmful, yet are routinely prescribed
  • Vince Flynn interviewed on WLS AM 890

    02/07/2012 8:43:24 AM PST · by fulltlt · 16 replies
    WLS AM 890 ^ | 2/7/2012
    Author, Vince Flynn was interviewed this morning on WLS AM 890 on the Don and Roma show. He talked quite a bit about his ordeal with stage 3 metastatic prostate cancer. It was a fascinating excellent, excellent interview. You can listen to it here.
  • Heart drug may be effective for managing certain cancers, study finds (nitroglycerin)

    12/14/2011 4:09:52 PM PST · by decimon · 4 replies
    Queen's University ^ | December 14, 2011
    Researchers at Queen’s University have identified a new mechanism that could potentially explain why the body’s immune system sometimes fails to eliminate cancer. The new findings shed light on the possible cause of immune resistance in cancer cells, and indicate that nitroglycerin, a relatively safe and low-cost drug used for more than a century to treat angina, may be effective for managing certain cancers. “This discovery may lead to new approaches for the treatment of patients with certain forms of cancer,” said Charles Graham, a professor in the Department of Biomedical and Molecular Sciences who lead the Queen’s research team...
  • Draft Guidelines Recommend Against PSA Screening: USPSTF Review

    10/25/2011 10:38:07 AM PDT · by dangerdoc · 11 replies
    Medscape ^ | 10/13/11 | Zosia Chustecka
    Clinical Context Few topics in the field of preventive medicine are contentious as prostate cancer screening. Widespread screening for prostate cancer has had a remarkable effect on the epidemiology of this tumor, as demonstrated in a study by Welch and Albertsen published in the October 7, 2009, issue of the Journal of the National Cancer Institute. Their study found that the introduction of routine prostate cancer screening led to approximately 1.3 million more men being diagnosed with prostate cancer in the United States alone. Men younger than 60 years accounted for most of this surge in cases. The authors estimated...
  • When Fighting Cancer Is Folly

    10/13/2011 11:48:09 AM PDT · by Kaslin · 33 replies · 1+ views ^ | October 13, 2011 | Steve Chapman
    Whenever I have a medical appointment, my wife inquires, "What did the doctor say?" I always give the same answer: "She said I'm going to die." Not because I have some fatal illness, but because life is a terminal condition. Americans might keep that fact in mind in considering the recent news made by the U.S. Preventive Services Task Force. It recently recommended against routine screening of healthy men for prostate cancer, on two grounds: The test doesn't save lives, on balance, and the treatments are usually worse than the disease. Everyone who gets prostate cancer will die. But usually...
  • National study finds vitamin E supplement may increase prostate cancer risk

    10/11/2011 1:43:46 PM PDT · by decimon · 26 replies
    Cleveland Clinic ^ | October 11, 2011 | Unknown
    Updated trial data show 17 percent increase in cancer riskCleveland: Men who take a daily vitamin E supplement – a regimen once thought to reduce cancer risk – face an increased risk of prostate cancer, according to results of a large national study. The finding comes from a report summarizing the latest results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Eric Klein, M.D., chair of the Glickman Urological and Kidney Institute at Cleveland Clinic, is the lead author. SELECT began in 2001 to test earlier research suggesting selenium and vitamin E supplements may reduce the risk of...
  • Panel’s Advice on Prostate Test Sets Up Battle (Obama's death panels alert)

    10/08/2011 7:47:29 AM PDT · by jimbo123 · 67 replies
    NY Times ^ | 10/8/11 | GARDINER HARRIS
    A day after a government panel said that healthy men should no longer get screened for prostate cancer, some doctors’ groups and cancer patients’ advocates began a campaign to convince the nation that the advice was misguided. Their hope is to copy the success of women’s groups that successfully persuaded much of the country two years ago that it was a mistake for the same panel, the United States Preventive Services Task Force, to recommend against routine mammograms for women in their 40s.
  • Panel's Pitch to Nix Routine Prostate Cancer Tests Draws Strong Reaction

    10/07/2011 10:56:02 PM PDT · by neverdem · 33 replies
    PBS' Newshour ^ | Oct. 7, 2011 | Interrogatory
    Transcript JEFFREY BROWN: Men shouldn't be routinely tested for prostate cancer. That was the recommendation today of an influential government panel that looked at whether PSA tests can extend lives by detecting cancer earlier.The tests measure levels of a protein made in the prostate. But the U.S. Preventive Services Task Force said they do more harm than good, including unnecessary biopsies, surgery, radiation and impotence. The panel concluded that -- quote -- "The common perception that early detection prolongs lives is not supported by the scientific evidence."Last year, more than 217,000 American men were diagnosed with prostate cancer; 32,000 died...
  • Medical group to say men don't need prostate cancer screenings, source says

    10/07/2011 8:49:36 AM PDT · by ConorMacNessa · 44 replies ^ | 7 Oct 2011 | Elizabeth Cohen
    The U.S. Preventive Services Task Force, the group that told women in their 40s that they don't need mammograms, will soon recommend that men not get screened for prostate cancer, according to a source privy to the task force deliberations. The task force is set to recommend a "D" rating for prostate specific antigen, or PSA, testing. Such a rating means "there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits," according to the group's website. The task force is set to propose this recommendation Tuesday, and then allow for...
  • Former Congressman Mark Foley has prostate cancer, surgery planned for Friday

    07/07/2011 5:51:05 PM PDT · by ConservativeStatement · 8 replies
    South Florida Sun-Sentinel ^ | July 7, 2011 | Anthony Man
    Former Congressman Mark Foley, diagnosed several weeks ago with an aggressive prostate cancer, will have surgery Friday morning to have his prostate removed. Foley, who was a Republican congressman from Palm Beach County for almost 12 years, said in a telephone interview that a battery of tests shows the cancer hasn’t spread beyond the prostate. But after consulting with medical experts and others who’ve had prostate cancer, he’s decided to have his prostate completely removed. He said the prognosis is for a speedy recovery, and he said he could be back at work as early as a week after the...
  • Ibuprofen: anticancer drug

    05/28/2011 9:44:31 AM PDT · by neverdem · 19 replies
    Chemistry World ^ | 26 May 2011 | Mike Brown
    Scientists in the UK have moved a step closer to understanding how ibuprofen could help treat cancer. The findings could lead to the drug being used as a preventative treatment for prostate cancer, in the future.Ibuprofen - a common painkiller - can help reduce the risk of prostate cancer, but the mechanism by which it inhibits tumour cells is still not fully understood. Now, Matthew Lloyd and his team from the University of Bath in the UK, in collaboration with Cancer Research UK, have uncovered a mechanism suggesting that the chiral inversion of ibuprofen inhibits the activity of the protein alpha-methylacyl-CoA...
  • High percentage of omega-3s in the blood may boost risk of aggressive prostate cancer

    04/25/2011 7:14:47 PM PDT · by decimon · 44 replies
    Fred Hutchinson Cancer Research Center ^ | April 25, 2011 | Unknown
    Conversely, high percentage of trans-fatty acids linked with lower riskSEATTLE – The largest study ever to examine the association of dietary fats and prostate cancer risk has found what's good for the heart may not be good for the prostate. Analyzing data from a nationwide study involving more than 3,400 men, researchers at Fred Hutchinson Cancer Research Center found that men with the highest blood percentages of docosahexaenoic acid, or DHA, an inflammation-lowering omega-3 fatty acid commonly found in fatty fish, have two-and-a-half-times the risk of developing aggressive, high-grade prostate cancer compared to men with the lowest DHA levels. Conversely,...
  • Biophysicist targeting IL-6 to halt breast, prostate cancer

    04/19/2011 4:27:11 PM PDT · by decimon · 5 replies
    Ohio Supercomputer Center ^ | April 19, 2011 | Unknown
    OSU's Li disrupts cellular messages through fragment-based drug design IMAGE: A simulation created at the Ohio Supercomputer Center by Ohio State’s Chenglong Li, Ph.D., illustrates MDL-A (ball-and-stick) binding with a section of GP130 (yellow ribbon). Li is using fragment-based drug... Click here for more information. An Ohio State biophysicist used a supercomputer to search thousands of molecular combinations for the best configuration to block a protein that can cause breast or prostate cancer. Chenglong Li, Ph.D., an assistant professor of medicinal chemistry and pharmacognosy at The Ohio State University (OSU), is leveraging a powerful computer cluster at the Ohio Supercomputer...
  • Study suggests another look at testosterone-prostate cancer link

    04/19/2011 10:03:56 AM PDT · by decimon · 3 replies
    Beth Israel Deaconess Medical Center ^ | April 19, 2011 | Unknown
    BOSTON – The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology. "For many decades it had been believed that a history of prostate cancer, even if treated and cured, was an absolute contraindication to testosterone therapy, due to the belief that testosterone activated prostate cancer growth, and could potentially cause dormant cancer cells to grow rapidly," says Abraham Morgentaler, MD of Men's Health Boston. "Generations of medical students and residents were taught that providing testosterone to a man with prostate cancer was...
  • Caution: Centralization Is Dangerous To Your Health

    04/08/2011 6:22:12 AM PDT · by Kaslin · 1 replies ^ | April 9, 2011 | Grace-Marie Turner
    The agency that runs the Medicare program decided in late March that it will pay for patients to receive an advanced new treatment for prostate cancer called Provenge. The decision was cheered by patient groups. The pressure was intense as they demanded that the Centers for Medicare and Medicaid Services (CMS) pay for the pioneering vaccine that already had been approved by the Food and Drug Administration. Early signals indicated the agency might deny payment because the drug is expensive. But Provenge is expensive because it is expensive to make. The drug is created individually using each patient’s own cells...
  • XMRV: Study Shows Virus Can Cause ‘Persistent Infection’ in Monkeys (ME/CFS related virus)

    02/19/2011 9:00:49 PM PST · by Seizethecarp · 9 replies
    Wall Street Journal Health Blog ^ | February 17, 2011 | Amy Dockser Marcus
    The debate over what XMRV may do to humans continues. But at least in a small group of monkeys, one thing is clear, according to a new study. “The virus causes chronic, persistent infection,” says Robert Silverman of the Cleveland Clinic, a co-author of the paper, which was published online yesterday in the Journal of Virology. Moreover, the new research suggests that in these monkeys, at least, the virus can be difficult to detect in blood, even though it’s taken root in the body. This is a tantalizing finding because it raises the prospect that someone could be infected with...
  • Chronic Fatigue Syndrome Not Caused by XMRV Virus, Study Finds - U.K. Study Overturns Previous...

    12/22/2010 8:37:48 PM PST · by neverdem · 21 replies · 1+ views
    WebMD Health News ^ | Dec. 20, 2010 | Tim Locke
    U.K. Study Overturns Previous Research Citing Virus as Cause of CFS Reviewed by Rob Hicks, MD Chronic fatigue syndrome is not caused by the virus XMRV, according to new research. A team from University College London, the Wellcome Trust Sanger Institute, and University of Oxford, all in England, says previous research linking the virus to chronic fatigue syndrome (CFS) was flawed because of contamination of mouse cell DNA samples in the laboratory. CFS is a disorder characterized by chronic fatigue lasting six months or longer, with several additional symptoms that may include impaired memory, unrefreshing sleep, muscle pain, sore throat,...
  • Finnish researchers find a compound that prevents the growth of prostate cancer cells

    12/20/2010 10:51:43 AM PST · by decimon · 5 replies
    VTT Technical Research Centre of Finland ^ | December 20, 2010 | Unknown
    Researchers from VTT Technical Research Centre of Finland and the University of Turku have demonstrated that an antibiotic called “monensin” prevents the growth of prostate cancer cells. Monensin is used in the meat and dairy industry, for example.Evidence pointing to the effects of monensin emerged in a project investigating the effects of nearly 5,000 drugs and micromolecules on the growth of prostate cancer cells. The project involved most of the drugs on the market today. Researchers found that small amounts of compounds – disulfiram (Antabus), thiram, tricostatin A, and monensin – can prevent the growth of prostate cancer cells without...
  • UCR scientists identify pomegranate juice components that could stop cancer from spreading

    12/12/2010 8:17:44 AM PST · by decimon · 16 replies · 1+ views
    University of California - Riverside ^ | December 12, 2010 | Unknown
    Research could lead to new drug therapies to fight cancerRIVERSIDE, Calif. – Researchers at the University of California, Riverside have identified components in pomegranate juice that both inhibit the movement of cancer cells and weaken their attraction to a chemical signal that promotes the metastasis of prostate cancer to the bone. The research could lead to new therapies for preventing cancer metastasis. Performed in the lab of Manuela Martins-Green, a professor of cell biology, the research was presented today (Dec. 12, 2010) at the 50th annual meeting of the American Society for Cell Biology taking place in Philadelphia. Prostate cancer...
  • Finger length predicts prostate cancer risk: study (a digit for your thoughts)

    11/30/2010 6:00:03 PM PST · by NormsRevenge · 55 replies · 3+ views
    AFP on Yahoo ^ | 11/30/10 | AFP
    PARIS (AFP) – Men whose index fingers are longer than their ring, or fourth, fingers run a significantly lower risk of prostate cancer, according to a study published Wednesday in the British Journal of Cancer. The chances of developing the disease drop by a third, and even more in younger men, the study found. "Our results show that relative finger length could be used as a simple test for prostate cancer risk, particularly in men aged under 60," said Ros Eeles, a professor at the Institute of Cancer Research in Britain and co-author of the study. Finger pattern could help...
  • XMRV virus found in 25% of breast cancer samples says U. of Utah research team

    11/25/2010 7:36:00 PM PST · by Seizethecarp · 10 replies
    World International Property Organization ^ | November 18, 2010 | Ila Ramnaresh Singh (lead inventor)
    [0003] The present inventors discovered that Xenotropic murine leukemia-related retrovirus (XMRV) has a strong link with human cancer, including prostate cancer and breast cancer. XMRV may also be associated with cervical cancer, hematologic malignancies, including lymphomas and leukemias, and non-cancerous conditions such as chronic fatigue syndrome and other neuroimmune diseases. This disclosure describes a series of methods to detect XMRV infection, and for use of that information in the diagnosis [0109] Additionally, 178 cases of breast cancer were examined for the presence of XMRV using the described methods. Approximately 25% of breast cancers contained either XMRV proviral DNA sequences or...
  • FDA Delay of One Drug Causes 82,000 Lost Life-Years

    10/28/2010 6:23:46 PM PDT · by facedodge · 8 replies ^ | Nov 2010 | William Faloon
    In 2004, I wrote an article describing how Americans die needlessly because of the FDA’s delay in approving lifesaving drugs.1 One example of a delayed therapy I cited was Provenge®, which in the year 2002 had demonstrated improved survival in prostate cancer patients.2 In 2007, Dr. Stephen Strum and I co-authored an article showing how enormous numbers of lives could be spared if scientists were liberated from oppressive FDA over-regulation. We described several cancer drugs that should have been approved including Provenge®, which by the year 2007 had extended survival in several clinical studies.3 In 2010, the FDA finally approved...
  • Death Panels Begin As Reform Takes Shape

    08/18/2010 4:52:33 PM PDT · by Kaslin · 20 replies
    IBD Editorials ^ | August 18, 2010 | Investors Business Daily staff
    Medicine: After the recess appointment of a Medicare and Medicaid head, an FDA panel drops its endorsement of a widely used cancer drug. Another FDA-approved cancer therapy may not be paid for. It begins. It didn't take long for the health care philosophy of Dr. Donald Berwick, President Obama's choice to head the Centers for Medicaid and Medicare Services, and an appointee we have labeled a "one-man death panel," to have an effect. Berwick is an admirer of Britain's National Health Service and its National Institute for Clinical Excellence, with the Orwellian-acronym NICE. "NICE," Berwick has said, "is extremely effective...
  • Redistributing Health?

    05/14/2010 5:43:54 PM PDT · by SmartInsight · 20 replies · 732+ views
    Investor's Business Daily ^ | May 14, 2010 | IBD Editorial
    Medicine: The administration's nominee to run Medicare and Medicaid is a fan of Britain's National Health Service and rationing services. He believes in less discretion for your doctor, more power for your government. 'The decision is not whether or not we will ration care — the decision is whether we will ration with our eyes open" is what Dr. Donald Berwick, President Obama's nominee to head the Centers for Medicaid and Medicare Services, said in an interview published in Biotechnology Healthcare in June 2009. The question is whether the Senate will confirm Berwick with open eyes. Berwick says: "NICE is...
  • FDA approves immune-boosting therapy for prostate cancer

    04/30/2010 6:15:59 AM PDT · by SeekAndFind · 2 replies · 252+ views
    Los Angeles Times ^ | 04/30/2010 | Thomas H. Maugh II
    The Food and Drug Administration approved a new immune-boosting therapy for prostate cancer on Thursday, the first therapeutic vaccine for cancer ever approved by the agency. The approval opens the door to a whole new approach to cancer therapy, adding a unique weapon to the arsenal of oncologists. The vaccine, Provenge, has been shown to extend survival in patients with advanced prostate cancer by four months, more than twice as long as chemotherapy, and to increase three-year survival by 38%. A lot of people have been working in labs, biotechs and pharma companies looking for a proof of principle" that...
  • Prostate Cancer Vaccine May Get FDA Approval (Help, not cure)

    04/27/2010 4:17:29 PM PDT · by decimon · 2 replies · 219+ views
    HealthDay News ^ | Apr 27, 2010 | Steven Reinberg
    The anticipated approval this week of a therapeutic prostate cancer vaccine by the U.S. Food and Drug Administration could be a milestone against the disease and cancer in general, experts say. The vaccine, called Provenge, appears to extend survival in men with advanced prostate cancer, and it does so without the serious side effects associated with chemotherapy, radiation and hormone therapy. "It is certainly exciting to see a drug that has made it this far and appears on the threshold of approval," said Dr. J. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society. The vaccine is...
  • Nanoparticle kit could diagnose disease early

    03/28/2010 6:40:56 PM PDT · by neverdem · 6 replies · 276+ views
    Nature News ^ | 23 March 2010 | Katharine Sanderson
    Colour change shows the presence of minuscule amounts of key enzymes. Enzymes snip apart the links between nanoparticles, prompting a colour change.Laromaine, A. et al. A detection kit that uses nanoparticles to seek out tiny amounts of disease-related enzymes could offer sensitive and fast diagnoses of cancer, HIV and other diseases.The diagnostic test has been developed and refined by Molly Stevens, a biomedical materials scientist at Imperial College London, and her colleagues. Stevens presented recent work on the test at the American Chemical Society meeting in San Francisco, California, on 21 March.In earlier experiments, Stevens made a test for enzymes...
  • Walnuts slow prostate tumors in mice

    03/22/2010 12:01:17 PM PDT · by decimon · 31 replies · 449+ views
    UC Davis research shows walnuts affect genes related to tumor growth(SACRAMENTO, Calif.) — Walnut consumption slows the growth of prostate cancer in mice and has beneficial effects on multiple genes related to the control of tumor growth and metabolism, UC Davis and the U.S. Department of Agriculture Western Regional Research Center in Albany, Calif. have found. The study, by Paul Davis, nutritionist in the Department of Nutrition and a researcher with the UC Davis Cancer Center, announced the findings today at the annual national meeting of the American Chemical Society in San Francisco. Davis said the research findings provide additional...
  • American Cancer Society urges docs about limitations of screening test for prostate cancer

    03/05/2010 8:57:34 PM PST · by FreeReign · 46 replies · 806+ views ^ | March 03, 2010, 2:15PM | Associated Press health & medical staff
    ATLANTA — The American Cancer Society is urging doctors to make clearer to men that the test used to screen for prostate cancer has limits and may lead to unnecessary treatments that do more harm than good. The cancer society has not recommended routine screening for most men since the mid-1990s, and that is not changing. But its new advice goes farther to warn of the limitations of the PSA blood test that millions of American men get now. It also says digital rectal exams should be an option rather than part of a standard screening.
  • Effective prostate cancer treatment discovery (Castration. But read on.)

    02/25/2010 2:32:26 PM PST · by decimon · 11 replies · 620+ views
    Monash University ^ | Feb 25, 2010 | Unknown
    Monash University biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers – the most common cancer in Australian men. For more than 60 years the main way to treat men with prostate cancer has involved removing the hormones that fuel growth of the cancer cells. Although initially effective this treatment inevitably fails and when the tumour growth resumes, the disease in incurable. The team, from the Prostate & Breast Cancer Research Program, has discovered a way to treat these potentially fatal diseased cells, which remain in a patient after they have undergone hormone...
  • Louis Gossett Jr. Says He Has Prostate Cancer

    02/09/2010 1:53:30 PM PST · by Touch Not the Cat · 16 replies · 466+ views
    cbs2 ^ | Feb 9, 2010 1:20 pm US/Pacific
    Oscar-winning actor Louis Gossett Jr. says he is being treated for prostate cancer. Gossett, who made the announcement Tuesday, says the disease was caught early and he expects to make a full recovery. The 73-year-old actor says he is going public about the disease because there is not enough emphasis in the African-American community on fighting it with preventive examinations and early treatment. Gossett has appeared in dozens of films. He won an Oscar for best supporting actor in 1983 for his portrayal of the no-nonsense Navy flight school sergeant who whips Richard Gere into shape in "An Officer and...
  • Chronic Fatigue Syndrome Attacked Again

    01/11/2010 12:37:17 PM PST · by neverdem · 44 replies · 1,395+ views
    ScienceNOW Daily News ^ | 6 January 2010 | Sam Kean
    Enlarge ImageControversial link. A previous study of chronic fatigue syndrome pointed to a retrovirus found in cancerous prostate cells (magnified in inset).Credit: ROBERT SCHLABERG AND HARSH THAKER Here we go again. Late last year, scientists seemed to be homing in on the cause of chronic fatigue syndrome (CFS)—excessive tiredness and other symptoms that have no known biological cause--by finding a supposed viral link. But a new paper challenges that link, a development that may plunge the field back into the same confusion and acrimony that has characterized it for years. Many CFS patients report that their symptoms began after...